Skip to content
Physician-backed infrastructure for aesthetic & wellness practicesSupport 9 AM–5 PM EST ·(888) 996-6173 ·info@medgrid.com
MedGrid
FDA Daily · today's issue

FDA daily for Thursday, October 15, 2026

36 FDA records across 4 sections. 1 touches MedGrid's categories and is listed first.

36FDA Records
4 of 7Sections With Data
1Touch MedGrid Categories

Today's Sections

Drug shortagesCovers FDA's Wed, Oct 14 (yesterday)
6
  • Everolimus Tablet

    Everolimus, Tablet, .25 mg (NDC 49884-158-02) — Par Health, USA LLC

    New · To Be Discontinued · Transplant

  • Dexmedetomidine Hydrochloride Injection

    Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02) — Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)

    Revised · Current · Anesthesia

  • Everolimus Tablet

    Everolimus, Tablet, .5 mg (NDC 49884-159-02) — Par Health, USA LLC

    New · To Be Discontinued · Transplant

  • Dexmedetomidine Hydrochloride Injection

    Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02) — Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)

    New · To Be Discontinued · Anesthesia

  • Everolimus Tablet

    Everolimus, Tablet, 1 mg (NDC 49884-283-02) — Par Health, USA LLC

    New · To Be Discontinued · Transplant

  • Everolimus Tablet

    Everolimus, Tablet, .75 mg (NDC 49884-160-02) — Par Health, USA LLC

    New · To Be Discontinued · Transplant

Drug approvalsCovers FDA's Thu, Oct 8 (a week ago)
1 touch MedGrid14
  • TECENTRIQ HYBREZATouches MedGrid categories

    ATEZOLIZUMAB AND HYALURONIDASE-TQJS — GENENTECH INC

    BLA761347 · Efficacy

  • PITOLISANT

    PITOLISANT — ANNORA PHARMA PRIVATE LIMITED

    ANDA218832 · Original approval

  • TECENTRIQ

    ATEZOLIZUMAB — GENENTECH INC

    BLA761034 · Efficacy

  • OXYCODONE HYDROCHLORIDE

    OXYCODONE HYDROCHLORIDE — ALVOGEN

    ANDA202116 · Labeling

  • WELTRUZA

    OLANZAPINE — TEVA NEUROSCIENCE INC

    NDA219007 · Original approval

  • BREZTRI AEROSPHERE

    BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE — ASTRAZENECA AB

    NDA220290 · Original approval

  • FENOFIBRATE

    FENOFIBRATE — PRINSTON INC

    ANDA211080 · Labeling

  • TAFLUPROST

    TAFLUPROST — SANDOZ

    ANDA209040 · Labeling

  • TAFLUPROST

    TAFLUPROST — MICRO LABS

    ANDA209051 · Labeling

  • CARBIDOPA AND LEVODOPA

    CARBIDOPA, LEVODOPA — MYLAN

    ANDA075091 · Labeling

  • FENOFIBRIC ACID

    CHOLINE FENOFIBRATE — IMPAX LABS INC

    ANDA200264 · Labeling

  • OXCARBAZEPINE

    OXCARBAZEPINE — BIOCON PHARMA

    ANDA218278 · Labeling

Showing 12 of 14. Search the rest in openFDA.

Drug recallsCovers FDA's Thu, Oct 8 (a week ago)
Nothing from FDA for this date
Food and supplement recallsCovers FDA's Thu, Oct 8 (a week ago)
Nothing from FDA for this date
Device recallsCovers FDA's Thu, Oct 8 (a week ago)
Nothing from FDA for this date
Device clearancesCovers FDA's Thu, Oct 1 (two weeks ago)
10
  • Firstar Dental Electric Motor

    FDC Technology Industry Co.

    K260027 · Substantially Equivalent · Dental

  • Dual Stage Venous Cannulae

    Sorin Group Italia S.R.L.

    K263092 · Substantially Equivalent · Cardiovascular

  • Firstar Dental Handpieces

    FDC Technology Industry Co.

    K260029 · Substantially Equivalent · Dental

  • Non-sterile, Powder Free Nitrile Examination Aloe Vera Green Gloves, Low Dermatitis Potential, Tested for use with Chem…

    Yty Industry (Manjung) Sdn Bhd

    K262208 · Substantially Equivalent · General Hospital

  • NEXUS® Hip Stem

    Microport Orthopedics, Inc.

    K262473 · Substantially Equivalent · Orthopedic

  • VITEK 2 AST-Streptococcus Meropenem (=0.06 - =4 µg/mL)

    bioMerieux, Inc.

    K260283 · Substantially Equivalent · Microbiology

  • SwiftSight-BodyComposition

    Airs Medical, Inc.

    K261612 · Substantially Equivalent · Radiology

  • Electronic Blood Pressure Monitor (BP-204C, BP-204A, BP-215, BP-203C, BP-205A, BP-201C, BP-217, BP-202C, BP-202 BP-205,…

    Shenzhen Brav Electronic Technologies Co., Ltd.

    K260470 · Substantially Equivalent · Cardiovascular

  • Intra-Operative Positioning System (IOPS) and IOPS Visionary System

    Centerline Biomedical

    K263016 · Substantially Equivalent · Cardiovascular

  • NOVIX Pedicle Screw System

    Tdm Co., Ltd.

    K263062 · Substantially Equivalent · Orthopedic

Label changesCovers FDA's Thu, Oct 1 (two weeks ago)
6
  • Daytime Sinus Severe

    Kroger Company

    Label version 3

  • Ultra Violette Sheen Screen Broad Spectrum Hydrating Lip Balm Dusk

    Grace And Fire USA Inc.

    Label version 5

  • Ultra Violette Sheen Screen Broad Spectrum Hydrating Lip Balm Bejewelled

    Grace And Fire USA Inc.

    Label version 5

  • CETIRIZINE HYDROCHLORIDE

    BAJAJ MEDICAL, LLC

    Label version 5

  • Banana Boat

    Edgewell Personal Care Brands LLC

    Label version 1

  • Drug label

    Label version 3

How the FDA Daily Is WrittenSources, dates and what gets flagged

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug recalls, device recalls and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Items that touch the categories MedGrid works in, such as GLP-1s, hormones, injectables, peptides, compounded products and aesthetic devices, are marked and listed first.

Subscribe with any feed reader, or point an email tool at theRSS feed. For the rules behind the headlines, see Regulations Research.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.

Recent Issues

  1. Thursday, October 15, 2026
  2. Wednesday, October 14, 2026
  3. Tuesday, October 13, 2026
  4. Monday, October 12, 2026
  5. Sunday, October 11, 2026
  6. Saturday, October 10, 2026
  7. Friday, October 9, 2026
  8. Thursday, October 8, 2026
  9. Wednesday, October 7, 2026
  10. Tuesday, October 6, 2026
  11. Monday, October 5, 2026
  12. Sunday, October 4, 2026
  13. Saturday, October 3, 2026
  14. Friday, October 2, 2026
  15. Thursday, October 1, 2026
  16. Wednesday, September 30, 2026
  17. Tuesday, September 29, 2026
  18. Monday, September 28, 2026
  19. Sunday, September 27, 2026
  20. Saturday, September 26, 2026
  21. Friday, September 25, 2026
  22. Thursday, September 24, 2026
  23. Wednesday, September 23, 2026
  24. Tuesday, September 22, 2026
  25. Monday, September 21, 2026
  26. Sunday, September 20, 2026
  27. Saturday, September 19, 2026
  28. Friday, September 18, 2026
  29. Thursday, September 17, 2026
  30. Wednesday, September 16, 2026

Issues go back 90 days.